Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Tuire Koufuye
- Development stage
- Unknown
- Lead developer
- Wuhan Juneng Jinshi Pharmaceutical
- Administration
- Oral
01
Overview
Xiao'er Tuire Koufuye is a traditional Chinese medicine (TCM) oral solution manufactured by Wuhan Juneng Jinshi Pharmaceutical Co., Ltd. (also known as Juneng Golden Key Pharmaceutical). It is an approved pharmaceutical product in China (NMPA registration number Z42021224) specifically indicated for pediatric use to treat symptoms associated with "wind-heat" type common colds. These symptoms include fever, aversion to wind, headache, red eyes, and sore throat. The formulation is composed of several herbal extracts, including Forsythia fruit (Lianqiao), Honeysuckle flower (Jinyinhua), Isatis root (Banlangen), Isatis leaf (Daqingye), Bupleurum root (Chaihu), Baical skullcap root (Huangqin), Gypsum (Shigao), Anemarrhena rhizome (Zhimu), Licorice root (Gancao), and Menthol (Bohenao). These components work synergistically to disperse wind, relieve exterior symptoms, clear heat, and detoxify the body.
- Brand names
- Juneng
- Other names
- Children's Fever Oral SolutionXiao'er Tuire Oral LiquidXiao'er Tuire Koufuye (Juneng)
Beyond the preview
Go deeper on Xiao'er Tuire Koufuye.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiao'er Tuire Koufuye.